Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of CareSusan Olender, Nirav Shah, Su Wang et al.|Clinical Infectious Diseases|2020Cited by 171
Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus RecommendationsMike Youle, José Vera, Schlomo Staszweski et al.|HIV Clinical Trials|2006Cited by 23
Short-Term Administration of the CCR5 Antagonist Vicriviroc to Patients With HIV and HCV Coinfection Is Safe and TolerableGerd Fätkenheuer, Dirk Schürmann, Christian Hoffmann et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2009Cited by 8